HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

6- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxaline

a TGF-betaR kinase inhibitor
Also Known As:
SB 525334; SB-525334; SB525334
Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Duggan, Nicholas: 2 articles (09/2014 - 02/2009)
2. Thomas, Matthew: 2 articles (09/2014 - 02/2009)
3. Budd, David C: 2 articles (01/2013 - 02/2009)
4. Laping, Nicholas J: 2 articles (05/2007 - 06/2005)
5. Naito, Seiji: 1 article (12/2015)
6. Itsumi, Momoe: 1 article (12/2015)
7. Shiota, Masaki: 1 article (12/2015)
8. Uchiumi, Takeshi: 1 article (12/2015)
9. Takeuchi, Ario: 1 article (12/2015)
10. Tatsugami, Katsunori: 1 article (12/2015)

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Fibrosis (Cirrhosis)
3. Right Ventricular Hypertrophy
4. Ureteral Obstruction
5. Pulmonary Fibrosis (Hamman Rich Syndrome)

Related Drugs and Biologics

1. Transforming Growth Factors (Transforming Growth Factor)
2. Transforming Growth Factor beta1 (TGF beta 1)
3. Transforming Growth Factor beta (TGF-beta)
4. Messenger RNA (mRNA)
5. Puromycin Aminonucleoside
6. Plasminogen Activators (Plasminogen Activator)
7. Phosphotransferases (Kinase)
8. Carbon Monoxide
9. 4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamide
10. alpha 1 chain collagen type I

Related Therapies and Procedures

1. Castration
2. Oral Administration